Hussain SM, Seeman E, Schneider HG, Ebeling PR, Barker AL, Polkinghorne K, et al. Association of serum phosphate, calcium and alkaline phosphatase with risk of incident fractures in healthy older adults. The Journal of Clinical Endocrinology & Metabolism, 2024 (in press).
DOI: 10.1210/clinem/dgae099
Campos-Obando N, Koek WNH, Hooker ER, et al. Serum phosphate is associated with fracture risk: the Rotterdam Study and MrOS. J Bone Miner Res. 2017;32(6):1182-93.
DOI: 10.1002/jbmr.3094
Barrera-Baena P, Rodríguez-García M, Rodríguez-Rubio E, González-Llorente L, Ortiz A, Zoccali, C et al. Serum phosphate is associated with increased risk of bone fragility fractures in haemodialysis patients. Nephrol Dial Transplant. 2024; 39: 618–626.
DOI: 10.1093/ndt/gfad190
Kwon YE, Choi HY, Kim S et al. Fracture risk in chronic kidney disease: a Korean population-based cohort study. Kidney Res Clin Pract. 2019; 38: 220–8.
DOI: 10.23876/j.krcp.18.0099
Roberts JL, Yu M, Viggeswarapu M, Arnst JL, Pacifici R, Beck GR Jr. Dietary phosphorus consumption alters T cell populations, cytokine production, and bone volume in mice. JCI Insight. 2023; 8(10): e154729.
DOI: 10.1172/jci.insight.154729
Szulc P, Blackwell T, Kiel DP, Schousboe JT, Cauley J, Hillier T, et al. Abdominal aortic calcification and risk of fracture among older women - The SOF study. Bone. 2015; 81:16-23.
DOI: 10.1016/j.bone.2015.06.019
Mazziotti G, Tupputi U, Ferrante G, Guglielmi G. Abdominal aortic calcification as a marker of relationship between atherosclerosis and skeletal fragility. J Clin Densitom. 2020; 23(4): 539-42.
DOI: 10.1016/j.jocd.2020.05.001
Zhang R, Lu Y, Ye L et al. Unique roles of phosphorus in endochondral bone formation and osteocyte maturation. J Bone Miner Res. 2011; 26: 1047–56.
DOI: 10.1002/jbmr.294
Khurrami L, Møller JE, Lindholt JS, Urbonaviciene G, Steffensen FH, Lambrechtsen J, et al. Cross-sectional study of aortic valve calcification and cardiovascular risk factors in older Danish men. Heart. 2021; 107(19): 1536-43.
DOI: 10.1136/heartjnl-2021-319023
Armas LA, Recker RR. Pathophysiology of osteoporosis: new mechanistic insights. Endocrinol Metab Clin North Am. 2012; 41(3):475-86.
DOI: 10.1016/j.ecl.2012.04.006
Davezac M, Buscato M, Zahreddine R, Lacolley P, Henrion D, Lenfant F, Arnal JF, Fontaine C. Estrogen receptor and vascular aging. Front Aging. 2021; 2:27380.
DOI: 10.3389/fragi.2021.727380
Adami S, Gatti D, Bertoldo F, Rossini M, Fratta-Pasini A, Zamberlan N, et al. The effects of menopause and estrogen replacement therapy on the renal handling of calcium. Osteoporos Int. 1992; 2(4): 180-5.
DOI: 10.1007/BF01623924
Genant HK, Wu CY, Van Kujik C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 1993; 8:1137–1148.
DOI: 10.1002/jbmr.5650080915
Naves M, Rodríguez-García M, Díaz-López JB, Gómez-Alonso C, Cannata-Andía JB. Progression of vascular calcifications is associated with greater bone loss and increased bone fractures. Osteoporos Int. 2008; 19(8): 1161-6.
DOI: 10.1007/s00198-007-0539-1
Kanatani M, Sugimoto T, Kano J, Chihara K. IGF-I mediates the stimulatory effect of high phosphate concentration on osteoblastic cell proliferation. J Cell Physiol. 2002; 190: 306–12.
DOI: 10.1002/jcp.10067
Beck GR, Zerler B, Moran E. Phosphate is a specific signal for induction of osteopontin gene expression. Proc Natl Acad Sci USA. 2000; 97: 8352–7.
DOI: 10.1073/pnas.140021997
Gupta A, Guo XL, Alvarez UM, Hruska KA. Regulation of sodiumdependent phosphate transport in osteoclasts. J Clin Invest. 1997; 100: 538–49.
DOI: 10.1172/JCI119563
Kanatani M, Sugimoto T, Kano J, Kanzawa M, Chihara K. Effect of high phosphate concentration on osteoclast differentiation as well as bone resorbing activity. J Cell Physiol. 2003; 196: 180–9.
DOI: 10.1002/jcp.10270
Koyama Y, Rittling SR, Tsuji K, Hino K, Salincarnboriboon R, Yano T, et al. Osteopontin deficiency suppresses high phosphate load-induced bone loss via specific modulation of osteoclasts. Endocrinology. 2006; 147: 3040–9.
DOI: 10.1210/en.2005-0671
Yates AJ, Oreffo ROC, Mayor K, Mundy GR. Inhibition of bone resorption by inorganic phosphate is mediated by both reduced osteoclast formation and decreased activity of mature osteoclasts. J Bone Miner Res. 1991; 6: 473–8.
DOI: 10.1002/jbmr.5650060508
M’Baya-Moutoula E, Louvet L, Metzinger-Le Meuth V, Massy ZA, Metzinger L. High inorganic phosphate concentration inhibits osteoclastogenesis by modulating miR-223. Biochim Biophys Acta. 2015; 1852: 2202–12.
DOI: 10.1016/j.bbadis.2015.08.003
Linefsky JP, O'Brien KD, Katz R, de Boer IH, Barasch E, Jenny NS, et al. Association of serum phosphate levels with aortic valve sclerosis and annular calcification: the cardiovascular health study. J Am Coll Cardiol. 2011; 58(3): 291-7.
DOI: 10.1016/j.jacc.2010.11.073
Linefsky JP, O'Brien KD, Sachs M, Katz R, Eng J, Michos ED, et al. Serum phosphate is associated with aortic valve calcification in the Multi-ethnic Study of Atherosclerosis (MESA). Atherosclerosis. 2014; 233(2): 331-7.
DOI: 10.1016/j.atherosclerosis.2013.12.051
Kinugasa M, Mori S, Takaya T, Ito T, Tanaka H, Satomi-Kobayashi S, et al. Serum phosphate is an independent predictor of the total aortic calcification volume in non-hemodialysis patients undergoing cardiovascular surgery. J Cardiol. 2016; 68(4): 308-15.
DOI: 10.1016/j.jjcc.2015.10.005
Citrin DL, Elson P, Kies MS, et al. Decreased serum phosphate levels after high-dose estrogens in metastatic prostate cancer. Possible implications. Am J Med. 1984; 76: 787–93.
DOI: 10.1016/0002-9343(84)90987-2
Stock JL, Coderre JA, Mallette LE. Effects of a short course of estrogen on mineral metabolism in postmenopausal women. J Clin Endocrinol Metab. 1985; 61: 595–600.
DOI: 10.1210/jcem-61-4-595
Uemura H, Irahara M, Yoneda N, et al. Close correlation between estrogen treatment and renal phosphate reabsorption capacity. J Clin Endocrinol Metab. 2000; 85: 1215–9.
DOI: 10.1210/jcem.85.3.6456
Faroqui S, Levi M, Soleimani M, Amlal H. Estrogen downregulates the proximal tubule type IIa sodium phosphate cotransporter causing phosphate wasting and hypophosphatemia. Kidney Int. 2008; 73(10): 1141-50.
DOI: 10.1038/ki.2008.33
Meng J, Ohlsson C, Laughlin GA, Chonchol M, Wssel CL, LjunggrenO, et al. Sex hormones and serum phosphorus in older men: The Osteoporotic Fractures in Men (MrOs) Study. Kidney Int. 2010; 78(4): 415–22.
DOI: 10.1038/ki.2010.161
Funakoshi T, Yanai A, Shinoda K, et al. G protein-coupled receptor 30 is an estrogen receptor in the plasma membrane. Biochem Biophys Res Commun. 2006; 346: 904–10.
DOI: 10.1016/j.bbrc.2006.05.191
Filardo EJ, Quinn JA, Frackelton AR Jr, et al. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol. 2002; 16: 70–84.
DOI: 10.1210/mend.16.1.0758
Björnström L, Sjöberg M. Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol Endocrinol. 2005;19: 833–842.
DOI: 10.1210/me.2004-0486
Qureshi R, Picon Ruiz M, Aurrekoetxea-Rodriguez I, Nunes de Paiva V, D’Amico M, Yoon H, et al. The major pre- and post-menopausal estrogens play opposing roles in obesity driven mammary inflammation and breast cancer development. Cell Metabolism 2020; 31(6): 1154-72.
DOI: 10.1016/j.cmet.2020.05.008
Key TJ, Appleby PN, Reeves GK, Travis RC, Brinton LA, Helzlsouer KJ et al. Steroid hormone measurements from different types of assays in relation to body mass index and breast cancer risk in postmenopausal women: Reanalysis of eighteen prospective studies. Steroids. 2015; 99(Pt A): 49-55.
DOI: 10.1016/j.steroids.2014.09.001
Fernández-Villabrille S, Martín-Carro B, Martín-Vírgala J, Alonso-Montes C, Fernández-Fernández A, Martínez-Salgado C, et al. Phosphorus may induce phenotypic transdifferentiation of vascular smooth muscle cells through the reduction of microRNA-145. Nutrients. 2023; 27;15(13): 2918.
DOI: 10.3390/nu15132918
Manolis AA, Manolis TA, Melita H, Mikhailidis DP, Manolis AS. Low serum albumin: A neglected predictor in patients with cardiovascular disease. Eur J Intern Med. 2022; 102: 24-39.
DOI: 10.1016/j.ejim.2022.05.004